Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Strengthening the Measurement of Adolescents' Mental Health at the Population Level

Kabiru CW, Blum RW. Elsevier BV. Journal of Adolescent Health. 2022;
Download PDF
Publication

Preliminary assessment of antivenom availability and management in the public health system of Costa Rica: An analysis based on a survey to pharmacists in public health facilities

Montoya-Vargas W, Gutiérrez JM, Quesada-Morúa MS, et al. Elsevier BV. Toxicon: X. 2022;
Download PDF
Publication

Natural products as lead compounds for treatment of neglected tropical diseases: dream or reality?

Moraes JD, Ghilardi Lago JH. Future Science Ltd. Future Medicinal Chemistry. 2022;
Publication

Effects of Ivermectin Mass Drug Administration for Malaria Vector Control on Ectoparasites and Soil-Transmitted Helminths: A Cluster Randomised Trial

Kositz C, Drammeh M, Vasileva H, et al. Elsevier BV. International Journal of Infectious Diseases. 2022;
Download PDF
Publication

Use of mobile tele-dermatology in managing cutaneous leishmaniasis from a remote district of Nepal during the COVID 19 pandemic: A case series

Parajuli N, Prajapati B. SAGE Publications. Tropical Doctor. 2022;
Publication

Knowledge, experiences, and practices of women affected by female genital schistosomiasis in rural Madagascar: A qualitative study on disease perception, health impairment and social impact

Schuster A, Randrianasolo BS, Rabozakandraina OO, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (11) : e0010901.
Download PDF
Publication

Pushing Down the Walls: Advocating for “Rehabilitation for All” in South Africa

Cobbing S, Gaede B, Chetty V, et al. Stichting Liliane Fonds. Disability, CBR & Inclusive Development. 2022; 33 (3) : 68.
Download PDF
Publication

Access to Public Healthcare Rehabilitation Services by Persons with Disabilities in South Africa: a Scoping Review

Van Biljon HM, Salie B, Van Wyk JC, et al. Stichting Liliane Fonds. Disability, CBR & Inclusive Development. 2022; 33 (3) : 41.
Download PDF
Publication

Community burden of intestinal parasites and its public health concerns in Obizi, Amakama Olokoro, Umuahia South, Abia State, Nigeria

Okosa C, Ukpai OM, Lawrence QO. Springer Science and Business Media LLC. Journal of Parasitic Diseases. 2022;
Publication

Why is health literacy failing so many?

The Lancet . Elsevier BV. The Lancet. 2022; 400 (10364) : 1655.

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 287
  • Page 288
  • Page 289
  • Page 290
  • Current page 291
  • Page 292
  • Page 293
  • Page 294
  • Page 295
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD